相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis
Moriko Ito et al.
CLINICAL CANCER RESEARCH (2011)
Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
Keinosuke Ryu et al.
BMC CANCER (2010)
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma
Zhenfeng Duan et al.
CANCER LETTERS (2010)
Clinical Implications of the Cancer Genome
Laura E. MacConaill et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Experimental Therapies and Clinical Trials in Bone Sarcoma
Rashmi Chugh
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients' prognosis
Quan Zhou et al.
MEDICAL ONCOLOGY (2010)
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
James E. Butrynski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs
Melissa C. Paoloni et al.
PLOS ONE (2010)
Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer
James M. Cleary et al.
CURRENT ONCOLOGY REPORTS (2010)
Functional genome screen for therapeutic targets of osteosarcoma
Umio Yamaguchi et al.
CANCER SCIENCE (2009)
Novel therapeutic agents for osteosarcoma
Kathleen O'Day et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
Zhenfeng Duan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
Laura E. MacConaill et al.
PLOS ONE (2009)
Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors
Serena S. Freeman et al.
CANCER (2008)
Major response to imatinib mesylate in KIT-mutated melanoma
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer
Zhenfeng Duan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis
Yong Hannah Wen et al.
HUMAN PATHOLOGY (2007)
Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome
Christian Kersting et al.
CLINICAL CANCER RESEARCH (2007)
High-throughput oncogene mutation profiling in human cancer
Roman K. Thomas et al.
NATURE GENETICS (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Alexander J. Chou et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
TK Man et al.
BMC CANCER (2004)
Survival data for 648 patients with osteosarcoma treated at one institution
HJ Mankin et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
The patterns of relapse in osteosarcoma: The Memorial Sloan-Kettering Experience
SN Chi et al.
PEDIATRIC BLOOD & CANCER (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Biology and therapeutic advances for pediatric osteosarcoma
N Marina et al.
ONCOLOGIST (2004)
Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma
CC Lau et al.
GENES CHROMOSOMES & CANCER (2004)
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site
GA Ulaner et al.
HUMAN MOLECULAR GENETICS (2003)
A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of plk1 in u-2 OS cells
YS Seong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
